Article / Jun 01, 2015
Developing an Orally Inhaled Dry Powder Formulation - A Complex Itinerary and a Technological Challenge
Pharmaceutical Technology, June 2015
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Our service for HPAPIs ranges from Drug Substance to Particle Engineering.
Hovione has experience in carrying out reactions at low temperatures.
Hovione has vast experience in developing hydrogenation processes using both heterogeneous and homogeneous catalysis.
Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.
Hovione has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.